Bühler appoints Christoph Goppelsroeder to its board of directors
Swiss equipment and systems firm Bühler has unanimously elected Christoph Goppelsroeder to the company’s Board of Directors at an extraordinary general shareholders meeting, writes Neill Barston.
The 62 year-old, who studied Civil Engineering at ETH in Zurich and holds an MBA from Insead, Fontainebleau, and has gained considerable executive experience during his career in driving innovation throughout his respective roles.
A Swiss national, he began his career at The Boston Consulting Group. From 1994 to 2003, he held management positions at Roche Vitamins in Switzerland, Belgium, and the US. He joined DSM through their acquisition of Roche’s Vitamins business in 2003 when he co-led the integration of Roche Vitamins and acted as DSM Managing Board member from 2005 to 2006. From 2007 to 2012, he oversaw Syngenta’s Global Seed Care Division.
In 2013, Christoph Goppelsroeder was appointed President and CEO of DSM Nutritional Products, DSM’s largest business, and Member of DSM’s Executive Committee. He led the division on a robust growth path, both organically as well as through acquisitions. He retired on April 1, 2021.
The group has continued on a path of developing new and innovative systems, including machinery for the confectionery sector, though the past 12 months have presented challenging conditions for the business.
However, despite its turnover impacted amid the pandemic, its CEO expressed optimism earlier this year at its digital session that its 12,000-strong global workforce would gain confidence from its digitally-focused business recovery plan. Among its recent moves has been a key drive with the German Institute of Food Technologies (DIL) to complete the inauguration of the Technology Centre Proteins of the Future in Germany, which is believed to hold significant product potential.
